I comunicati stampa vengono rilasciati da FUJIFILM Corporation in Giappone.
Fujifilm non garantisce in alcun modo che questi comunicati stampa siano disponibili in tutti i Paesi e in tutte le regioni.
I contenuti di questo sito Web sono aggiornati alla data dell’annuncio da parte della stampa e possono essere soggetti a modifiche senza preavviso. Le informazioni contenute in ciascuna versione, inclusi la disponibilità del prodotto, le specifiche, i prezzi, i contatti, sono quelle presenti al momento della pubblicazione.
- Gen 6, 2023
- FUJIFILM Cellular Dynamics Announces License Agreement with Novo Nordisk for the Development of iPSC-Derived Cell Therapies
- Dic 13, 2022
- Fujifilm to Build an Advanced Semiconductor Materials Manufacturing Facility in South Korea
- Nov 22, 2022
- Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility
- Ott 19, 2022
- Fujifilm develops “FUJINON HZK25-1000mm”
- Ott 6, 2022
- Fujifilm to establish its first Bio-CDMO site in Japan
- Ott 3, 2022
- Fujifilm to establish a local subsidiary in South Korea to accelerate business growth of cell culture media
- Set 8, 2022
- Fujifilm announces a strategic investment in a new production facility in Kumamoto Japan to support the fast-growing semiconductor industry
- Lug 6, 2022
- Fujifilm launches FUJIFILM PROJECTOR Z6000
- Lug 1, 2022
- Fujifilm launches world’s first mobile app “FUJIFILM Prescale Mobile” that quantifies pressure based on color development on pressure measurement film
- Giu 30, 2022
- Fujifilm to Invest USD 1.6 billion to enhance and expand its global offering of cell culture manufacturing services
- Giu 8, 2022
- Fujifilm Acquires European Inkjet System Integrator UNIGRAPHICA to Expand Inkjet Integration Business Globally
- Mag 9, 2022
- Fujifilm reveals FUJIFILM PROJECTOR Z6000
- Apr 5, 2022
- Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Mar 29, 2022
- Fujifilm Completes Acquisition of Shenandoah Biotechnology
- Mar 28, 2022
- Fujifilm Invests in a new manufacturing facility for inkjet pigment dispersions in the U.S.
- Mar 23, 2022
- Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
- Gen 26, 2022
- Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Dic 8, 2021
- Fujifilm Kicks Off Operations at its New, State-of-the-Art Cell Culture Media Manufacturing Facility in Europe
- Dic 1, 2021
- FUJIFILM Irvine Scientific Establishes a Bioprocessing Innovation and Collaboration Center in China (FUJIFILM Irvine Scientific)
- Ott 20, 2021
- Fujifilm launches 4K-compatible broadcast lens with 107× zoom “FUJINON UA107x8.4BESM”